ICF - Institut Català de Finances
VC Fund
Barcelona, Spain
ICF - Institut Català de Finances is a VC fund in Barcelona focused on Health Care and Medical. ICF - Institut Català de Finances provides financial services.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 69%
Last updated:
For AI agents: llms.txt
Industries ICF - Institut Català de Finances invests in
Stages ICF - Institut Català de Finances invests in
Countries ICF - Institut Català de Finances invests in
Round sizes
Round size
- Seed
- $2.4M–$2.9M
- Debt Financing
- $1.7M–$12M
Investment Focus
Industry
- Health Care 4 (25%)
- Medical 3 (19%)
- Biotechnology 3 (19%)
- Manufacturing 3 (19%)
- Pharmaceutical 3 (19%)
Stage
- Debt Financing 11 (69%)
- Seed 2 (13%)
- Series C 1 (6%)
- Funding Round 1 (6%)
- Post-IPO Debt 1 (6%)
Country
- Spain 13 (81%)
- Germany 1 (6%)
- United Kingdom 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Open Cosmos is a space technology company that designs, builds, and operates satellites to simplify access to space. The company also delivers end-to-end telecommunications, Earth Observation (EO), navigation, and scientific missions. It designs, builds, launches and operates advanced satellites through its OpenOrbit offering, that enablesorganizations to access and share data via its mutualized OpenConstellation infrastructure and offers AI-powered data analysis from a growing range of satellite sources and analytic partners through its DataCosmos platform. | $346.4M / Series C / Sep 14, 2026 | ||
|
Delta Renovables
|
Delta Renovables specializes in the creation, promotion, operation, and maintenance of renewable energy projects. | $4.6M / Debt Financing / Aug 04, 2026 | |
| Ercros is a chemical manufacturing company that focuses on the basic products for the chemical and pharmaceutical industries. The company diversified in three areas of activity such as the Pharmacy Division, the Chlorine Derivatives Division, and the Intermediate Chemistry Division. It maintains a leading position in the main markets in which it ispresent and exports almost half of its sales to more than 128 countries, mainly in the EU.Ercros was founded in 1989 and is headquartered in Barcelona, Spain. | $22.8M / Post-IPO Debt / Jul 27, 2026 | ||
| Super’s Diana develops, manufactures, and markets medicines and supplements for swine, cattle, and poultry livestock in over 30 countries. | May 07, 2026 | ||
| D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population. | $2.4M / Seed / Feb 23, 2026 | ||
| LABIANA GROUP has unique operational flexibility and a great capacity to offer high quality contract manufacturing services to all companies in the sector, regardless of batch size required. | $43.6M / Debt Financing / Feb 19, 2026 | ||
| Phyture Biotech was born as a spin-off company of the Faculty of Pharmacy at the Univerisity of Barcelona (Universitat de Barcelona), created by scientists from the research group Plant Biotechnology: Production of Phytomedicines (2009 SGR 1217). Phyture Biotech builds on the knowledge developed by this research group during more than 30 years,creating commercial products and solutions.Belonging to the Plant Biotechnology sector, Phyture Biotech is specialised in the production of high value active ingredients and recombinant proteins, for its use in the cosmetics and pharmaceutical sectors.Phyture has since renamed to Vytrus Biotech in 2016. | $2.3M / Debt Financing / Jan 14, 2026 | ||
| Rubió is a pharmaceutical company that offers medicines, diagnoses, and nutrition products. | $4.7M / Debt Financing / Jul 16, 2025 | ||
| GEDIA develops and manufactures car body press parts and welding components for the automotive industry. | $9.5M / Debt Financing / May 06, 2025 | ||
| Calsina Carré Services offers parking, fueling, electric car charging and vehicle maintenance. | $11.8M / Debt Financing / Dec 11, 2024 | ||
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does ICF - Institut Català de Finances invest in?
ICF - Institut Català de Finances invests primarily in Health Care, Medical and Biotechnology startups, most often at Debt Financing and Seed stage. Most of the 16 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does ICF - Institut Català de Finances invest in?
ICF - Institut Català de Finances typically joins rounds of $2.4M–$2.9M at Seed and $1.7M–$12M at Debt Financing. These are whole funding-round sizes, not ICF - Institut Català de Finances's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds ICF - Institut Català de Finances took part in.
When did ICF - Institut Català de Finances last invest?
The most recent investment recorded for ICF - Institut Català de Finances closed in Sep 2026. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
